Blog
RSS FeedPosted by Michael Wonder on 12 Jun 2019
The Cancer Drugs Fund in practice and under the new framework
12 June 2019 - The Cancer Drugs Fund was established in 2010 to improve access to treatments not routinely available. ...
Posted by Michael Wonder on 31 Jan 2018
CDF to save NHS £140m over five years
31 January 2018 - At least £140 million is expected to be released into the NHS over the next five ...
Posted by Michael Wonder on 07 Jun 2017
Cancer Drugs Fund of minimal benefit
6 June 2017 - A new study has concluded that the medicines available in the previous version of the NHS Cancer ...
Posted by Michael Wonder on 26 May 2017
Conservatism and the cancer drugs fund
24 May 2017 - Are some patients—and some people— more deserving than others? ...
Posted by Michael Wonder on 01 May 2017
Cancer fund failure highlights the dilemma of drug pricing
1 May 2017 - The challenge is to keep treatments affordable but still encourage innovation. ...
Posted by Michael Wonder on 29 Apr 2017
Cancer Drugs Fund condemned as expensive and ineffective
28 April 2017 - Treatments approved by David Cameron’s scheme were not worth money, extended life very little and often had ...
Posted by Michael Wonder on 29 Sep 2016
Cancer Drugs Fund requires further reform
27 September 2016 - Reliance on “real world” observational data undermines evidence base for clinical practice. ...
Posted by Michael Wonder on 11 Aug 2016
A novel UK approach to cancer access: yes, no, or maybe?
10 August 2016 - What are the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients? ...
Posted by Michael Wonder on 02 Aug 2016
Rare cancer drug which significantly delays progression of advanced thyroid cancer is left off relaunched Cancer Drugs Fund
2 August 2016 - People with radioiodine refractory differentiated thyroid cancer are overlooked as Lenvima (lenvatinib mesylate) is not scheduled for ...
Posted by Michael Wonder on 01 Aug 2016
Make drug makers pay: England’s strategy for cancer medicines
29 July 2016 - Roche, Pfizer concerned new system has no spending limit. ...
Posted by Michael Wonder on 13 Jun 2016
Cancer Drugs Fund 2.0: a missed opportunity?
14 June 2016 - The UK National Health Service, like most other developed health care systems, has struggled with how to ...
Posted by Michael Wonder on 13 Jun 2016
Why cancer?
14 June 2016 - Throughout my career as a health economist, one issue has always been a mystery to me—why does ...
Posted by Michael Wonder on 08 Jun 2016
The Cancer Drugs Fund
8 June 2016 - Over the past five years thousands of patients in England have been given access to new but ...
Posted by Michael Wonder on 11 Feb 2016
'I wouldn't want to be a cancer patient in England': Drug company boss slams NHS watchdog for denying patients life-changing treatments
11 February 2016 - Erik Nordkamp, managing director of Pfizer UK, said England already had one of the poorest outcomes for ...
Posted by Michael Wonder on 11 Feb 2016
Ministers scramble to introduce new NHS cancer drugs scheme
11 February 2016 - Ministers have less than two months to thrash out a new system for financing cancer drugs in ...